Cell death biomarkers are associated with development of hepatorenal syndrome as well as response to terlipressin therapy

Authors :: D Sollinger
T Austgen
J Ahrens
PR Galle
Jens U. Marquardt
J Rey
V Sivanathan
MA Wörns
M Nguyen-Tat
Source :: Zeitschrift für Gastroenterologie. 54
Publication Year :: 2016
Publisher :: Georg Thieme Verlag KG, 2016.

Subjects :: Programmed cell death
medicine.medical_specialty
Hepatorenal syndrome
business.industry
Internal medicine
Gastroenterology
medicine
business
Terlipressin
medicine.disease
medicine.drug

Full Text Access

Tools